|
1
|
Ritter J and Bielack SS: Osteosarcoma. Ann
Oncol. 21:vii320–vii325. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Wafa H and Grimer RJ: Surgical options and
outcomes in bone sarcoma. Expert Rev Anticancer Ther. 6:239–248.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Zetter B: Adhesion molecules in tumor
metastasis. J Exp Med. 4:219–229. 1993.
|
|
4
|
Wolf SF, Lee K, Swiniarski H, O’toole M
and Sturmhoefel K: Cytokines and cancer immunotherapy. Immunol
Invest. 29:143–146. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Li Y, Flores R, Yu A, et al: Elevated
expression of CXC chemokines in pediatric osteosarcoma patients.
Cancer. 117:207–217. 2011. View Article : Google Scholar
|
|
6
|
Smyth MJ, Thia KY, Street SE, et al:
Differential tumor surveillance by natural killer (NK) and NKT
cells. J Exp Med. 191:661–668. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Davidson WF, Giese T and Fredrickson TN:
Spontaneous development of plasmacytoid tumors in mice with
defective Fas-Fas ligand interactions. J Exp Med. 187:1825–1838.
1998. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Lin EY, Nguyen AV, Russell RG and Pollard
JW: Colony-stimulating factor 1 promotes progression of mammary
tumors to malignancy. J Exp Med. 193:727–740. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Li B, Yang Y, Jiang S, Ni B, Chen K and
Jiang L: Adenovirus-mediated overexpression of BMP-9 inhibits human
osteosarcoma cell growth and migration through downregulation of
the PI3K/AKT pathway. Int J Oncol. 41:1809–1819. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Khan N, Cromer CJ, Campa M and Patz EF:
Clinical utility of serum amyloid A and macrophage migration
inhibitory factor as serum biomarkers for the detection of nonsmall
cell lung carcinoma. Cancer. 101:379–384. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Lu J, Getz G, Miska EA, et al: MicroRNA
expression profiles classify human cancers. Nature. 435:834–838.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
de Noo ME, Tollenaar RA, Özalp A, et al:
Reliability of human serum protein profiles generated with C8
magnetic beads assisted MALDI-TOF mass spectrometry. Anal Chem.
77:7232–7241. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Oh Y-H, Hong M-Y, Jin Z, et al: Chip-based
analysis of SUMO (small ubiquitin-like modifier) conjugation to a
target protein. Biosens Bioelectron. 22:1260–1267. 2007. View Article : Google Scholar
|
|
14
|
Zhou H, Bouwman K, Schotanus M, et al:
Two-color, rolling-circle amplification on antibody microarrays for
sensitive, multiplexed serum-protein measurements. Genome Biol.
5:R282004. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Huang R-P, Huang R, Fan Y and Lin Y:
Simultaneous detection of multiple cytokines from conditioned media
and patient’s sera by an antibody-based protein array system. Anal
Biochem. 294:55–62. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Wang CC, Huang RP, Sommer M, et al:
Array-based multiplexed screening and quantitation of human
cytokines and chemokines. J Proteome Res. 1:337–343. 2002.
View Article : Google Scholar
|
|
17
|
Pitha-Rowe I, Petty WJ, Feng Q, et al:
Microarray analyses uncover UBE1 L as a candidate target gene for
lung cancer chemoprevention. Cancer Res. 64:8109–8115. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Tannapfel A, Anhalt K, Häusermann P, et
al: Identification of novel proteins associated with hepatocellular
carcinomas using protein microarrays. J Pathol. 201:238–249. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Dahlin DC and Coventry MB: Osteogenic
sarcoma. A study of six hundred cases. J Bone Joint Surg Am.
49:101–110. 1967.PubMed/NCBI
|
|
20
|
Johnson SC: Hierarchical clustering
schemes. Psychometrika. 32:241–254. 1967. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
de Hoon MJ, Imoto S, Nolan J and Miyano S:
Open source clustering software. Bioinformatics. 20:1453–1454.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
D’haeseleer P: How does gene expression
clustering work? Nat Biotechnol. 23:1499–1501. 2005. View Article : Google Scholar
|
|
23
|
Miller JC, Zhou H, Kwekel J, et al:
Antibody microarray profiling of human prostate cancer sera:
antibody screening and identification of potential biomarkers.
Proteomics. 3:56–63. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Gao WM, Kuick R, Orchekowski RP, et al:
Distinctive serum protein profiles involving abundant proteins in
lung cancer patients based upon antibody microarray analysis. BMC
cancer. 5:1102005. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Orchekowski R, Hamelinck D, Li L, et al:
Antibody microarray profiling reveals individual and combined serum
proteins associated with pancreatic cancer. Cancer Res.
65:11193–11202. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Himelstein BP, Asada N, Carlton MR and
Collins MH: Matrix metalloproteinase. 9 (MMP. 9) expression in
childhood osseous osteosarcoma. Med Pediatr Oncol. 31:471–474.
1998. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Bian ZY, Fan QM, Li G, Xu WT and Tang TT:
Human mesenchymal stem cells promote growth of osteosarcoma:
Involvement of interleukin. 6 in the interaction between human
mesenchymal stem cells and Saos 2. Cancer Sci. 101:2554–2560. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Coltella N, Manara MC, Cerisano V, et al:
Role of the MET/HGF receptor in proliferation and invasive behavior
of osteosarcoma. FASEB J. 17:1162–1164. 2003.PubMed/NCBI
|
|
29
|
Postiglione L, Di Domenico G, Caraglia M,
et al: Differential expression and cytoplasm/membrane distribution
of endoglin (CD105) in human tumour cell lines: implications in the
modulation of cell proliferation. Int J Oncol. 26:1193–1201.
2005.PubMed/NCBI
|
|
30
|
Kloen P, Gebhardt MC, Perez-Atayde A,
Rosenberg AE, Springfield DS, Gold LI and Mankin HJ: Expression of
transforming growth factorbeta (TGF-beta) isoforms in
osteosarcomas: TGF-beta3 is related to disease progression. Cancer.
80:2230–2239. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Sulzbacher I, Birner P, Trieb K, Träxler
M, Lang S and Chott A: Expression of platelet-derived growth
factor-AA is associated with tumor progression in osteosarcoma.
Modern Pathol. 16:66–71. 2003. View Article : Google Scholar
|
|
32
|
Lin SK, Kok SH, Yeh FT, et al: MEK/ERK and
signal transducer and activator of transcription signaling pathways
modulate oncostatin M-stimulated CCL2 expression in human
osteoblasts through a common transcription factor. Arthritis Rheum.
50:785–793. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Lehrke M, Millington SC, Lefterova M, et
al: CXCL16 is a marker of inflammation, atherosclerosis and acute
coronary syndromes in humans. J Am Coll Cardiol. 49:442–449. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Hojo S, Koizumi K, Tsuneyama K, et al:
High-level expression of chemokine CXCL16 by tumor cells correlates
with a good prognosis and increased tumor-infiltrating lymphocytes
in colorectal cancer. Cancer Res. 67:4725–4731. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Gutwein P, Schramme A, Sinke N, et al:
Tumoural CXCL16 expression is a novel prognostic marker of longer
survival times in renal cell cancer patients. Eur J Cancer.
45:478–489. 2009. View Article : Google Scholar
|
|
36
|
Wang B, Hendricks DT, Wamunyokoli F and
Parker MI: A growth-related oncogene/CXC chemokine receptor 2
autocrine loop contributes to cellular proliferation in esophageal
cancer. Cancer Res. 66:3071–3077. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Takamori H, Oades ZG, Hoch OC, Burger M
and Schraufstatter IU: Autocrine growth effect of il-8 and gro
[alpha] on a human pancreatic cancer cell line, capan-1. Pancreas.
21:52–56. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Li J and Sidell N: Growth related oncogene
produced in human breast cancer cells and regulated by Syk protein
tyrosine kinase. Int J Cancer. 117:14–20. 2005. View Article : Google Scholar : PubMed/NCBI
|
